PROP TX-TAX DISTRICT SURPLUS

104th Regular Session Introduced by Tony McCombie and 2 co-sponsors

House Bill 1321 ensures patients access noninvasive ventilators without step therapy barriers, mandates Medicaid reimbursement, and enhances care for chronic respiratory conditions.

Rule 19(a) / Re-referred to Rules Committee

Purpose of the Bill

House Bill 1321 aims to regulate the use of step therapy and fail first protocols concerning prescribed noninvasive ventilators. The intent is to ensure that patients requiring these medical devices receive timely access to the appropriate treatment without unnecessary barriers imposed by insurance providers.

Key Provisions

HB 1321 introduces several important changes to existing healthcare regulations:

Prohibition of Step Therapy and Fail First Protocols:

Healthcare insurers are prohibited from requiring step therapy or fail first protocols for noninvasive ventilators if:
- The ventilator requires substantial servicing as classified by the Centers for Medicare & Medicaid Services.
- Clinical evidence or patient history indicates that alternative treatments would be less effective or could cause adverse reactions.
- The ventilator is deemed medically necessary by the FDA.

Medicaid Reimbursement:

The Secretary of the Department of Human Services is mandated to ensure that Medicaid managed care organizations reimburse for noninvasive ventilators at no less than 100% of the Arkansas Medicaid Program's fee schedule.

Rulemaking Authority:

The Insurance Commissioner and the Secretary of the Department of Human Services are granted authority to develop rules for the implementation and administration of these provisions, which may also apply to state health benefit programs.

Impact of the Bill

Affected Parties:

The bill primarily impacts patients who require noninvasive ventilators, particularly those with chronic respiratory conditions such as COPD. It also affects healthcare insurers and Medicaid managed care organizations in Arkansas.

Financial Implications:

According to the actuarial statement, the bill is expected to have no financial impact on the Employee Benefits Division (EBD) plan, as it currently does not impose step therapy or fail-first requirements for qualifying members.

Legislative Timeline

Introduced: January 30, 2025

Committee Recommendations: Initially deferred by the HSG committee on February 5, 2025.

Progress: The bill passed through various readings and committee approvals, ultimately being returned from the Senate as passed on April 8, 2025.

Final Status: As of April 10, 2025, HB 1321 has been enacted as Act 513.

Conclusion

House Bill 1321 represents a significant step towards improving access to necessary medical devices for patients in Arkansas. By eliminating restrictive protocols for noninvasive ventilators, the bill aims to enhance patient care and ensure that individuals receive the most appropriate treatment without undue delay.

Bill